All
Hyperhidrosis in teens: Multicenter prospective study validates use of botulinum toxin
August 10th 2009Intradermal injection of onabotulinumtoxinA (Botox, Allergan) is a safe, effective and well-tolerated treatment for primary axillary hyperhidrosis in adolescent patients, according to the findings of a prospective, multicenter Phase 4 study.
Managing UV-induced pigmentary disorders: New, affordable products complement sunscreen
August 6th 2009Boston - Patients and dermatologists have new options in the management of pigmentary disorders resulting from decades of sun exposure, according to Ranella A. Hirsch, M.D., clinical assistant professor of dermatology, Boston University Medical Center.
Extension set for "Red Flags" rule
August 6th 2009Physicians have received yet another extension in the deadline for complying with the "Red Flags" rule requiring programs to guard against identity theft. The Federal Trade Commission (FTC), the agency which developed the rule and is responsible for implementing it, announced in late July that it was moving the deadline for compliance from August 1 to November 1.
Nevi of special site: Conservative treatment approach justified
August 5th 2009Nevi of special site can be seen not only in children and adolescents, but in adults up to age 35 as well, according to a recent study. A conservative approach to treating these nevi is justified given they do not appear to have the potential for malignancy.
TNF blockers boost risk of lymphoma, FDA says
August 5th 2009Washington - The Food and Drug Administration (FDA) says an increased risk of lymphoma and other cancers is associated with the use of drugs like Remicade (Centocor) and Humira (Abbott) in children and adolescents, the Wall Street Journal reports.
FDA adds warning for Botox, similar products; changes generic names
August 4th 2009Washington - The Food and Drug Administration (FDA) has approved a new warning on Allergan's Botox and a similar product about the possibility of life-threatening breathing and swallowing problems, following up on an earlier announcement about tougher warnings.
Unique development: Pyoderma gangrenosum appear during ulcerative colitis
August 4th 2009In a recent case study, a patient receiving infliximab for the treatment of ulcerative colitis paradoxically developed widespread pyoderma gangrenosum lesions, a disease which normally responds well to this biologic therapy.
Managing surgical wounds: Laser-activated tissue repair trumps standard surgical closure
August 4th 2009A recent study ushers in the era of molecular surgery as laser-assisted "nanosuturing" proves to be superior to traditional suture closing techniques not only in terms of cosmesis but also in the tensile strength and quality of wound closure. According to Dr. Sandy Tsao, who spearheaded the first human clinical trial, this novel technique is set to change the way physicians approach and manage surgical wounds in the future.
Powder dressing: Easy-to-apply woundcare product creates optimal conditions for healing
August 4th 2009A new transforming powder dressing (Altrazeal, ULURU) is an easy-to-apply woundcare product that creates optimal conditions for healing. It has been used with excellent outcomes in a variety of acute and chronic wounds, including skin graft donor sites, pressure ulcers, venous ulcers, and diabetic foot ulcers.
Healing potential: Adult stem cells may be useful for wounds
August 4th 2009Adult stem cells may have a greater role in wound healing in the future, an expert says. Researchers are conducting tissue-engineering research with bovine models to assess the feasibility of stem cells to heal wounds in bones, cartilage and tendons.
Systemic therapy: Doctors eye fresh approaches to cutaneous lupus
August 4th 2009Both topical and systemic therapies are used in patients with cutaneous lupus erythematosus. According to one expert, the antimalarials are still the safest and often effective treatment approach. However, newer therapies may offer some hope in those especially challenging to treat recalcitrant cases of CLE.
A watchful eye: Population-based study refutes anecdotes that cutaneous lupus is on the rise
August 4th 2009The results of a recent population-based study confirms that the incidence of Cutaneous lupus erythematosus is not two to three times higher than the incidence of the more severe systemic lupus erythematosus form of the autoimmune disease, as anecdotally once thought.
Unveiling leprosy: 4,000-year-old skeleton from India now earliest evidence of disease
August 1st 2009World report - A 4,000-year-old skeleton discovered in Balathal, India, bearing signs of leprosy is the earliest known skeletal evidence of the disease, and is also the first evidence of leprosy in prehistoric India.The online journal PloS One published the research by Appalachian State anthropologists in May of this year.